Russell Investments Group
PCVX icon

Russell Investments Group’s Vaxcyte PCVX Stock Holding History

Russell Investments Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.55M Buy
164,334
+126,155
+330% +$6.85M 0.01% 1105
2026
Q1 		$2.22M Buy
38,179
+21,724
+132% +$1.18M ﹤0.01% 1829
2025
Q4 		$759K Sell
16,455
-517
-3% -$23.1K ﹤0.01% 2341
2025
Q3 		$611K Sell
16,972
-12,420
-42% -$411K ﹤0.01% 2396
2025
Q2 		$956K Sell
29,392
-170,198
-85% -$5.58M ﹤0.01% 2084
2025
Q1 		$7.54M Buy
199,590
+91,201
+84% +$7.29M 0.01% 946
2024
Q4 		$8.87M Buy
108,389
+29,442
+37% +$2.92M 0.01% 866
2024
Q3 		$9.02M Buy
78,947
+59,988
+316% +$5.41M 0.01% 879
2024
Q2 		$1.43M Buy
18,959
+101
+0.5% +$6.88K ﹤0.01% 1806
2024
Q1 		$1.29M Buy
+18,858
New +$1.31M ﹤0.01% 1876
2023
Q3 		– Sell
-805
Closed -$40.2K – 3601
2023
Q2 		$40.2K Hold
805
– – ﹤0.01% 2750
2023
Q1 		$30.2K Buy
+805
New +$34.1K ﹤0.01% 2771
2021
Q1 		– Sell
-22,229
Closed -$590K – 3176
2020
Q4 		$590K Buy
+22,229
New +$826K ﹤0.01% 2359

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Russell Investments Group's PCVX Position: Q2 2026 in Review

Russell Investments Group increased its Vaxcyte (PCVX) stake by 330% in Q2 2026, buying an estimated $6.85M and bringing the position to 164,334 shares worth $9.55M. The position accounts for 0.01% of the portfolio, ranked #1105.

Russell Investments Group first reported a position in PCVX in Q4 2020 and has held it in 13 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Russell Investments Group held 164,334 shares of Vaxcyte worth $9.55M as of Q2 2026.
  • Russell Investments Group bought 126,155 Vaxcyte shares in Q2 2026, an estimated $6.85M.
  • Vaxcyte made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1105 holding.
  • Russell Investments Group first reported a position in Vaxcyte in Q4 2020 and has held it in 13 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.